Short answer
PACS Group, Inc. (PACS) filed an 8-K current report with the SEC on March 5, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Patrick H. Conway, MD, MSc appointed to PACS Board effective March 4, 2026 as Class III director.
PACS Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Patrick H. Conway, MD, MSc appointed to PACS Board effective March 4, 2026 as Class III director
- Term runs through 2027 annual stockholder meeting
- Compensation follows standard non-employee director program per Nov 25, 2025 proxy filing
- No disclosed conflicts, related-party transactions, or arrangements behind the appointment: clean governance signal
Item 7.01 · Regulation FD Disclosure
- New director appointment announced via press release dated March 5, 2026
- Board composition change signals potential shift in governance or strategic direction: identity and background of appointee key to assessing impact
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PACS Group, Inc. 8-K filings
Get the next PACS 8-K as it lands
Follow PACS for push alerts, or ask the research agent what this filing means.